ESR1 and breast carcinoma: They suggested that IFI27/ISG12 is an important factor in regulating ERα activity in breast cancer cells and a potential target of future strategies to control the growth and proliferation of ERα-positive breast cancer (Cervantes-Badillo et al. 2020).